News & Updates

Following discontinuation of nucleot(s)ide analogue therapy, only about one-third of patients with HBeAg-negative chronic hepatitis B (CHB) achieve disease remission, with rare HBsAg loss, as reported in a study. The likelihood of HBsAg loss and disease remission is high in the presence of very low HBsAg levels at baseline.

The use of hormonal replacement therapy (HRT) among postmenopausal women may be associated with a reduced risk of mortality after a COVID-19 diagnosis, according to a retrospective study from Sweden.

A group of researchers from Singapore has recently developed a finger stick blood test that can rapidly and semi-quantitatively assess the neutralizing antibody (nAb) response of people who have been vaccinated against COVID-19.

The overall rate of hospitalization for COVID-19 is low among patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs) who have been vaccinated against COVID-19, according to a prospective study from England. However, patients on ocrelizumab or fingolimod have elevated hospitalization rates.

COVID-19 vaccination appears to reduce the odds of long COVID symptoms, with continuous improvement following a second dose, at least in the first few months after the shot, suggests a study.

Sepsis or septic shock and bacterial meningitis, which are associated with non-negligible morbidity and mortality, frequently occur in infants with group B Streptococcus (GBS) late-onset disease (LOD), reports a recent study.